Back

Manager, I2S & AP Regulatory Reporting

AmgenAmgen·Biotechnology

Apply effort

<60 sec

via Aplyr Quick Apply

Posted

38 days

01

About the role

Career Category

Engineering

Job Description

The Manager will serve as the on-the-ground leader of the Invoice to Settle (I2S) operational team based in Amgen India (Hyderabad), with operational accountability for a four-person team spanning three core I2S towers: invoice processing, global payments, and statement reconciliation.  This role will also support AP Regulatory Reporting activity across the enterprise, with a particular focus on withholding tax and unclaimed property. This is an integral role that combines daily operations management, people leadership, and partnership with global I2S function owners. 

The manager owns local execution, team performance, and stakeholder experience, while operating within a matrixed model: the global function owners set process standards, tooling direction, and priorities for their respective towers in collaboration with this role. The Manager, I2S Operations will ensure consistent delivery, coaching, and capacity allocation across the team.

.
02

Aplyr's read

Amgen is a biotechnology leader focused on innovative therapeutics in oncology, cardiovascular, and inflammation, attracting professionals in science, engineering, and data analytics.

Synthesized from recent postings & public sources

What's promising

  • Strong focus on cutting-edge biotechnology and human therapeutics.
  • Diverse career opportunities in scientific, engineering, and data roles.
  • Commitment to addressing serious health conditions like cancer and cardiovascular disease.

What to watch

  • Highly competitive industry with constant innovation demands.
  • Regulatory challenges in developing and marketing new therapies.
  • Potential for high-pressure work environment due to ambitious goals.

Why Amgen

  • Pioneering in biologic therapies with a focus on serious diseases.
  • Robust pipeline of innovative drugs in various therapeutic areas.
  • Global presence with a strong emphasis on research and development.

Aplyr’s read is generated by AI from public sources. Was it useful?

03

About Amgen

AMGN$410.94+1.51%

Amgen is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. The company focuses on areas such as oncology, cardiovascular disease, and inflammation.

04

Similar roles